Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Bringing immunoglobulin knowledge up to date: how should we treat today?

Literature DB >> 21762127

Bringing immunoglobulin knowledge up to date: how should we treat today?

S Misbah¹, T Kuijpers, J van der Heijden, B Grimbacher, D Guzman, J Orange.

Abstract

Immunoglobulin (Ig) therapy is constantly evolving. Advances in the basic and clinical science of immunoglobulins have provided new perspectives in using polyclonal IgG to treat patients with primary immunodeficiencies. Recent meta-analyses of patient data and outcomes, optimization of IgG administration and better understanding of the IgG receptor variability and clinical effect are new concepts which practising immunologists can use in tailoring their approach to treating patients with primary immunodeficiencies. This manuscript presents the proceedings of a satellite symposium, held in conjunction with the European Society for Immunodeficiencies (ESID) 2010 meeting, to inform attendees about new scientific concepts in IgG therapy, with the goal of empowering expert level evaluation of what optimal IgG therapy is today.

Entities: Disease Species

Mesh：

Substances：

Year: 2011 PMID： 21762127 PMCID： PMC3193915 DOI： 10.1111/j.1365-2249.2011.04443.x

Source DB: PubMed Journal: Clin Exp Immunol ISSN： 0009-9104 Impact factor: 4.330

45 in total

1. Efficacy and safety of Hizentra(®) in patients with primary immunodeficiency after a dose-equivalent switch from intravenous or subcutaneous replacement therapy.

Authors: S Jolles; E Bernatowska; J de Gracia; M Borte; V Cristea; H H Peter; B H Belohradsky; V Wahn; J Neufang-Hüber; O Zenker; B Grimbacher
Journal: Clin Immunol Date: 2011-06-12 Impact factor: 3.969

2. Pulmonary abnormalities in patients with primary hypogammaglobulinemia.

Authors: L Kainulainen; M Varpula; K Liippo; E Svedström; J Nikoskelainen; O Ruuskanen
Journal: J Allergy Clin Immunol Date: 1999-11 Impact factor: 10.793

3. Respiratory disorders in common variable immunodeficiency.

Authors: M A Martínez García; M D de Rojas; M D Nauffal Manzur; M P Muñoz Pamplona; L Compte Torrero; V Macián; M Perpiñá Tordera
Journal: Respir Med Date: 2001-03 Impact factor: 3.415

Review 4. Common variable immune deficiency: respiratory manifestations, pulmonary function and high-resolution CT scan findings.

Authors: K M Thickett; D S Kumararatne; A K Banerjee; R Dudley; D E Stableforth
Journal: QJM Date: 2002-10

5. Immunoglobulin therapy to control lung damage in patients with common variable immunodeficiency.

Authors: Javier de Gracia; Montserrat Vendrell; Antonio Alvarez; Esther Pallisa; Maria-José Rodrigo; David de la Rosa; Fernando Mata; Jordi Andreu; Ferran Morell
Journal: Int Immunopharmacol Date: 2004-06 Impact factor: 4.932

Review 6. Subcutaneous immunoglobulin replacement in primary immunodeficiencies.

Authors: Melvin Berger
Journal: Clin Immunol Date: 2004-07 Impact factor: 3.969

7. Comparison of the efficacy of IGIV-C, 10% (caprylate/chromatography) and IGIV-SD, 10% as replacement therapy in primary immune deficiency. A randomized double-blind trial.

Authors: Chaim M Roifman; Harry Schroeder; Melvin Berger; Ricardo Sorensen; Mark Ballow; Rebecca H Buckley; Anita Gewurz; Phillip Korenblat; Gordon Sussman; Georg Lemm
Journal: Int Immunopharmacol Date: 2003-09 Impact factor: 4.932

Review 3. Progress in gammaglobulin therapy for immunodeficiency: from subcutaneous to intravenous infusions and back again.

Authors: Richard L Wasserman
Journal: J Clin Immunol Date: 2012-07-25 Impact factor: 8.317

Bringing immunoglobulin knowledge up to date: how should we treat today?

1. Efficacy and safety of Hizentra(®) in patients with primary immunodeficiency after a dose-equivalent switch from intravenous or subcutaneous replacement therapy.

2. Pulmonary abnormalities in patients with primary hypogammaglobulinemia.

3. Respiratory disorders in common variable immunodeficiency.

Review 4. Common variable immune deficiency: respiratory manifestations, pulmonary function and high-resolution CT scan findings.

5. Immunoglobulin therapy to control lung damage in patients with common variable immunodeficiency.

Review 6. Subcutaneous immunoglobulin replacement in primary immunodeficiencies.

7. Comparison of the efficacy of IGIV-C, 10% (caprylate/chromatography) and IGIV-SD, 10% as replacement therapy in primary immune deficiency. A randomized double-blind trial.

8. Rates of pneumonia during influenza epidemics in Seattle, 1964 to 1975.

9. Enteroviral infections in primary immunodeficiency (PID): a survey of morbidity and mortality.

10. Efficacy of intravenous immunoglobulin on the prevention of pneumonia in patients with agammaglobulinemia.

1. Broadening the translational immunology landscape.

2. Immunoglobulin therapy for refractory Crohn's disease.

Review 3. Progress in gammaglobulin therapy for immunodeficiency: from subcutaneous to intravenous infusions and back again.

Review 4. Subcutaneous immunoglobulin for primary and secondary immunodeficiencies: an evidence-based review.

5. Therapeutic immunoglobulin should be dosed by clinical outcome rather than by body weight in obese patients.

6. Subcutaneous immunoglobulin therapy: a new option for patients with primary immunodeficiency diseases.